November 3, 2022
João Dürr reviewed the past year and described the CDCB vision in the CEO Column from the 2022 Activity Report.
April 12, 2022
January 6, 2022
To start the new year, CEO João Dürr previews CDCB goals and expectations for 2022.
A monthly newsletter, details genetic evaluation updates and industry news.